TY - JOUR T1 - <sup>18</sup>F-FDG PET/CT Imaging Features of Cardiac Arrhythmia in a Patient Treated with Panitumumab JF - Journal of Nuclear Medicine Technology JO - J. Nucl. Med. Technol. SP - 360 LP - 361 DO - 10.2967/jnmt.121.262216 VL - 49 IS - 4 AU - Pokhraj P. Suthar AU - Jagadeesh S. Singh AU - Khushboo Gupta Y1 - 2021/12/01 UR - http://tech.snmjournals.org/content/49/4/360.abstract N2 - Panitumumab is a new humanized antiepidermal growth factor receptor monoclonal antibody (mAb) approved for the treatment of advanced colorectal cancer. There is an increase in the use of this drug due to a good response rate and possible secondary resection in advanced colorectal cancer. Here, we present 18F-FDG PET/CT imaging findings of cardiac arrhythmia in a patient receiving panitumumab for the treatment of metastatic infiltrating rectal adenocarcinoma. Cardiotoxicity is a known adverse effect associated with panitumumab. So far, to our knowledge, no documented imaging findings for the same are available in the literature. ER -